CORNING, NY — Corning Incorporated (NYSE: GLW) will highlight its latest technologies in automation and 3D cell culture at this year's Society for Laboratory Automation and Screening (SLAS) conference in San Diego, California, Saturday, Feb. 25- Wednesday, Mar. 1.
Corning Life Sciences will showcase a suite of 3D culture tools, including the new Elplasia® 12K flask and a soon-to-be-released Elplasia plate with an open-well format to enable ease of spheroid and organoid manipulations. True to the core of SLAS, the company will also demonstrate its benchtop automation technology, including the Corning Matribot® Bioprinter, Corning Lambda™ EliteMax Semi-automated Benchtop Pipettor, and Corning® Cell Counter, all of which enable a more automated workflow in a small footprint.
John Tobin, Vice President & General Manager of Corning Life Sciences, will be onsite to discuss how the industry is driving innovation and how Corning is vital to the industry’s progress.
“We’re determined to enable faster, more efficient workflows in drug discovery because we are intensely aware of the potential impact,” Tobin says. “By working with our customers to overcome workflow hurdles in critical areas of study, we can help accelerate the timeline of new treatment options and inspire hope across patient populations.”
To commence this year’s event, Corning is sponsoring the welcome reception on Sunday, Feb. 26 from 5:30 p.m.-7:00 p.m. PST, where all attendees–from students to C-suite executives–are invited to network with experts and to explore the exhibit hall. To celebrate Corning Life Sciences’ commitment to innovation and the planet, the company will be donating to One Tree Planted, an environmental non-profit focused on reforestation, to plant a tree for each attendee that visits Booth #1610 during the conference.
“Organizations across the life sciences industry are making climate initiatives a top priority,” says Tobin. “Importantly, we agree. And we’re challenging ourselves to find new ways to decrease our carbon footprint across the company. We hope to inspire our customers to do the same.”
Corning’s drug discovery portfolio and automation solutions show only a glimpse of the innovation to come in the year ahead. Join Corning experts and several customers sharing their technical presentations throughout the event (register here), including:
Product Demonstrations
- Demonstrations of the Corning Matribot Bioprinter, the Corning Lambda EliteMax Semi-automated Benchtop Pipettor, and the Corning Cell Counter:
- Monday, Feb. 27, 2023, 3 p.m. – 5 p.m. PST
- Tuesday, Feb. 28, 2023, 10 a.m. – 12 p.m. PST
- Location: Booth #1610
Short Course
- Level Up Your 3D Cell Culture–From Research to High Throughput
- Sunday, Feb. 26, 2023
- 10:30 a.m. – 2:30 p.m. PST
- Presented by: Tom Bongiorno, PhD, Field Applications Scientist, Corning Life Sciences, Oksana Sirenko, PhD, Molecular Devices, Angeline Lim, PhD, Molecular Devices
- Location: 6E
Tutorials
- A Simplified Approach for Rapid Analysis of Thousands of Intact Spheroids Using the Velocyt LP Large Particle Flow Cytometer
- Monday, Feb. 27, 2023
- 2:00 p.m. – 3:00 p.m. PST
- Presented by: John O’Rourke, PhD, MBA, President and CEO BennuBio, Inc
- Location: 4
- Genes or Environment? Investigating the Relative Contribution of Mutations, Nutrient Availability, and 2D vs 3D Growth on the Metabolism of Cancer Cells
- Tuesday, Feb. 28, 2023
- 9:00 a.m. – 10:00 a.m. PST
- Presented by: Jonathan Braverman, PhD, Principal Investigator, Innovative Genomics Institute
- Location: 15B
Solutions Spotlight
- 3D Cell Culture Solutions to Maximize Biological Complexity and Throughput
- Tuesday, Feb. 28, 2023
- 11:30 a.m. – 11:50 a.m. PST
- Presented by: Austin Mogen, PhD, Field Application Scientist Manager, Corning Life Sciences
- Location: #230 in Exhibition
Poster Session
- The EVidential Importance of Cell Culture Conditions and Their Impact on Stem Cell Derived Extracellular Vesicles for Acellular Therapies
- Tuesday, Feb. 28, 2023
- 12:00 p.m. – 1:00 p.m. PST
- Presented by: Pilar Pardo, Sr. Development Scientist, Corning Life Sciences
- Poster Assignment Number: 1086-C
To learn about how Corning is helping advance 3D cell culture with innovative technologies and workflow solutions, visit the company's exhibit, Booth #1610, or schedule a meeting (virtually or in-person) with a member of the Corning executive team. To schedule, please contact:
Carmen Lopez
(773) 306-6285
clopez@spectrumscience.com
###
Caution Concerning Forward-Looking Statements
This press release contains "forward-looking statements" (within the meaning of the Private Securities Litigation Reform Act of 1995), which are based on current expectations and assumptions about Corning's financial results and business operations, that involve substantial risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include: the duration and severity of the recent COVID-19 (coronavirus) outbreak, and its ultimate impact across our businesses on demand, operations and our global supply chains; the effects of acquisitions, dispositions and other similar transactions by the Company, the effect of global business, financial, economic and political conditions; tariffs and import duties; currency fluctuations between the U.S. dollar and other currencies, primarily the Japanese yen, New Taiwan dollar, euro, Chinese yuan, and South Korean won; product demand and industry capacity; competitive products and pricing; availability and costs of critical components and materials; new product development and commercialization; order activity and demand from major customers; the amount and timing of our cash flows and earnings and other conditions, which may affect our ability to pay our quarterly dividend at the planned level or to repurchase shares at planned levels; possible disruption in commercial activities due to terrorist activity, cyber-attack, armed conflict, political or financial instability, natural disasters, or major health concerns; unanticipated disruption to equipment, facilities, IT systems or operations; effect of regulatory and legal developments; ability to pace capital spending to anticipated levels of customer demand; rate of technology change; ability to enforce patents and protect intellectual property and trade secrets; adverse litigation; product and components performance issues; retention of key personnel; customer ability, most notably in the Display Technologies segment, to maintain profitable operations and obtain financing to fund their ongoing operations and manufacturing expansions and pay their receivables when due; loss of significant customers; changes in tax laws and regulations including the Tax Cuts and Jobs Act of 2017; and the potential impact of legislation, government regulations, and other government action and investigations.
For a complete listing of risks and other factors, please reference the risk factors and forward-looking statements described in our annual reports on Form 10-K and quarterly reports on Form 10-Q. Forward-looking statements speak only as of the day that they are made, and Corning undertakes no obligation to update them in light of new information or future events.
Web Disclosure
In accordance with guidance provided by the SEC regarding the use of company websites and social media channels to disclose material information, Corning Incorporated ("Corning") wishes to notify investors, media, and other interested parties that it uses its website to publish important information about the company, including information that may be deemed material to investors, or supplemental to information contained in this or other press releases. The list of websites and social media channels that the company uses may be updated on Corning's media and website from time to time. Corning encourages investors, media, and other interested parties to review the information Corning may publish through its website and social media channels as described above, in addition to the company's SEC filings, press releases, conference calls, and webcasts.
About Corning Incorporated
Corning (www.corning.com) is one of the world's leading innovators in materials science, with a 170-year track record of life-changing inventions. Corning applies its unparalleled expertise in glass science, ceramic science, and optical physics along with its deep manufacturing and engineering capabilities to develop category-defining products that transform industries and enhance people's lives. Corning succeeds through sustained investment in RD&E, a unique combination of material and process innovation, and deep, trust-based relationships with customers who are global leaders in their industries. Corning's capabilities are versatile and synergistic, which allows the company to evolve to meet changing market needs, while also helping its customers capture new opportunities in dynamic industries. Today, Corning's markets include optical communications, mobile consumer electronics, display, automotive, solar, semiconductors, and life sciences.